Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


08.10.2018

1 Am J Psychiatry
1 Br J Psychiatry
1 Cereb Cortex
1 Compr Psychiatry
1 J Psychiatry Neurosci
2 Neuropsychopharmacology
6 Psychiatry Res
1 Psychol Med
5 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Psychiatry

  1. MARTINEZ A, Gaspar PA, Hillyard SA, Andersen SK, et al
    Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.
    Am J Psychiatry. 2018 Oct 3:appiajp201818010072.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  2. MAYER A, Hanlon F, Teshiba T, Klimaj S, et al
    An fMRI study of multimodal selective attention in schizophrenia - CORRIGENDUM.
    Br J Psychiatry. 2018 Oct 3:1. doi: 10.1192/bjp.2018.
    PubMed     Text format    


    Cereb Cortex

  3. DONG D, Duan M, Wang Y, Zhang X, et al
    Reconfiguration of Dynamic Functional Connectivity in Sensory and Perceptual System in Schizophrenia.
    Cereb Cortex. 2018 Oct 1. pii: 5112936. doi: 10.1093.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  4. LEE JY, Chung YC, Song JH, Lee YH, et al
    Contribution of stress and coping strategies to problematic Internet use in patients with schizophrenia spectrum disorders.
    Compr Psychiatry. 2018;87:89-94.
    PubMed     Text format     Abstract available


    J Psychiatry Neurosci

  5. DONDAINE T, Philippot P, Batail JM, Le Jeune F, et al
    Apathy alters emotional arousal in chronic schizophrenia.
    J Psychiatry Neurosci. 2018;43:170172.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  6. SONNENSCHEIN SF, Gill KM, Grace AA
    State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia.
    Neuropsychopharmacology. 2018 Sep 18. pii: 10.1038/s41386-018-0219.
    PubMed     Text format     Abstract available

  7. MODINOS G, Simsek F, Azis M, Bossong M, et al
    Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
    Neuropsychopharmacology. 2018 Oct 2. pii: 10.1038/s41386-018-0118.
    PubMed     Text format     Abstract available


    Psychiatry Res

  8. FEFEU M, De Maricourt P, Cachia A, Hoertel N, et al
    One-year mirror-image study of the impact of olanzapine long-acting injection on healthcare resource utilization and costs in severe schizophrenia.
    Psychiatry Res. 2018;270:205-210.
    PubMed     Text format     Abstract available

  9. GOMEZ-GASTIASORO A, Pena J, Zubiaurre-Elorza L, Ibarretxe-Bilbao N, et al
    Spanish adaptation and validation of the situational feature recognition test 2 (SFRT-2) in patients with schizophrenia and healthy controls.
    Psychiatry Res. 2018;270:225-231.
    PubMed     Text format     Abstract available

  10. GONZALEZ-BLANCO L, Maria P Garcia-Portilla, Garcia-Alvarez L, Lorena de la Fuente-Tomas, et al
    Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia.
    Psychiatry Res. 2018;269:688-691.
    PubMed     Text format     Abstract available

  11. SAUVE G, Malla A, Joober R, Brodeur MB, et al
    Comparing cognitive clusters across first- and multiple-episode of psychosis.
    Psychiatry Res. 2018;269:707-718.
    PubMed     Text format     Abstract available

  12. MILJEVIC CD, Nikolic-Kokic A, Blagojevic D, Milovanovic M, et al
    Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.
    Psychiatry Res. 2018;269:746-752.
    PubMed     Text format     Abstract available

  13. GARCIA-CABEZA I, Diaz-Caneja CM, Ovejero M, de Portugal E, et al
    Adherence, insight and disability in paranoid schizophrenia.
    Psychiatry Res. 2018;270:274-280.
    PubMed     Text format     Abstract available


    Psychol Med

  14. CASSETTA BD, Tomfohr-Madsen LM, Goghari VM
    A randomized controlled trial of working memory and processing speed training in schizophrenia.
    Psychol Med. 2018 Oct 3:1-11. doi: 10.1017/S0033291718002775.
    PubMed     Text format     Abstract available


    Schizophr Res

  15. STORCHAK H, Hudak J, Haeussinger FB, Rosenbaum D, et al
    Reducing auditory verbal hallucinations by means of fNIRS neurofeedback - A case study with a paranoid schizophrenic patient.
    Schizophr Res. 2018 Sep 27. pii: S0920-9964(18)30576.
    PubMed     Text format    

  16. KRAUS MS, Walker TM, Jarskog LF, Millet RA, et al
    Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia.
    Schizophr Res. 2018 Sep 26. pii: S0920-9964(18)30542.
    PubMed     Text format     Abstract available

  17. ZHANG Z, Wang Y, Zhang Q, Zhao W, et al
    The effects of CACNA1C gene polymorphism on prefrontal cortex in both schizophrenia patients and healthy controls.
    Schizophr Res. 2018 Sep 27. pii: S0920-9964(18)30557.
    PubMed     Text format     Abstract available

  18. NGUYEN TT, Kosciolek T, Maldonado Y, Daly RE, et al
    Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects.
    Schizophr Res. 2018 Sep 26. pii: S0920-9964(18)30572.
    PubMed     Text format     Abstract available

  19. LOCH AA, Freitas EL, Hortencio L, Chianca C, et al
    Hearing spirits? Religiosity in individuals at risk for psychosis-Results from the Brazilian SSAPP cohort.
    Schizophr Res. 2018 Sep 25. pii: S0920-9964(18)30578.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: